Nephrology in Saint Joseph, MO
5 verified nephrology doctors in Saint Joseph.
Nephrologists treat kidney disease, high blood pressure, and disorders of fluid and electrolyte balance.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Missouri Board of Registration for the Healing Arts
Dr. Dennis Dobyan, MD
Nephrology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Scott Brown, MD
Nephrology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Susan Brown, MD
Nephrology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Fnu Neha, MD
Nephrology
CMS Open Payments· $15.31 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$15.31
Total received
2
Transactions
1
Paying companies
Top paying companies
Among the 10,935 nephrology doctors we've analyzed, about 59% received any industry payment (median $286 among those who did). This doctor's total is on the lower end — around the 44th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US nephrology doctors.
Payments to Fnu Neha do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Tomonori Oyadomari, MD
Nephrology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.